XIAP and Survivin as Therapeutic Targets for Radiation Sensitization in Preclinical Models of Lung Cancer

Oncogene - United Kingdom
doi 10.1038/sj.onc.1207929
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Springer Science and Business Media LLC

Related search

Radiation Sensitization in Breast Cancer via Targeting Survivin Expression

2006English

Molecular Pathways and Therapeutic Targets in Lung Cancer

Oncotarget
Oncology
2014English

miRNAs as Biomarkers and Therapeutic Targets in Non-Small Cell Lung Cancer: Current Perspectives

Targeted Oncology
Cancer ResearchOncologyPharmacology
2017English

Preclinical Models of Radiation Induced Lung Damage: Challenges and Opportunities for Small Animal Radiotherapy

British Journal of Radiology
MedicineNuclear MedicineRadiologyImaging
2019English

HER3 as Biomarker and Therapeutic Target in Pancreatic Cancer: New Insights in Pertuzumab Therapy in Preclinical Models

Oncotarget
Oncology
2014English

GEMMs as Preclinical Models for Testing Pancreatic Cancer Therapies

DMM Disease Models and Mechanisms
ImmunologyMolecular BiologyBiochemistryMicrobiology NeuroscienceMedicineGenetics
2015English

Rho GTPases as Therapeutic Targets in Cancer (Review)

International Journal of Oncology
Cancer ResearchOncology
2017English

Oncogenes as Therapeutic Targets in Cancer: A Review

IOSR Journal of Dental and Medical Sciences
2013English

Significant Therapeutic Efficacy With Combined Radioimmunotherapy and Cetuximab in Preclinical Models of Colorectal Cancer

Journal of Nuclear Medicine
MedicineNuclear MedicineRadiologyImaging
2015English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy